Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.14279/13696
Title: Galactorrhea, mastodynia and gynecomastia as the first manifestation of lung adenocarcinoma. A case report
Authors: Lazopoulos, Achileas 
Krimiotis, Dimitris 
Schizas, Nikolaos V. 
Rallis, Thomas 
Gogakos, A.S. 
Chatzinikolaou, Fotis 
Tsiouda, Theodora 
Zarogoulidis, Paul 
Sarafis, Pavlos 
Kamparoudi, Parthena 
Paliouras, Dimitrios V. 
Barbetakis, Nikolaos G. 
Major Field of Science: Medical and Health Sciences
Field Category: Clinical Medicine
Keywords: Galactorrhea;Gynecomastia;Lung adenocarcinoma;Mastodynia
Issue Date: 2019
Source: Respiratory Medicine Case Reports, 2019, vol. 26, pp. 146-149
Volume: 26
Start page: 146
End page: 149
Journal: Respiratory Medicine Case Reports 
Abstract: Gynecomastia with mastodynia and galactorrhea as a paraneoplastic syndrome due to lung cancer with complete response after surgical excision is rare. A 62-year-old Caucasian male presented with mastodynia, galactorrhea and right breast enlargement. Chest x-ray revealed a left upper lobe tumor. The patient had high levels of serum beta-human chorionic gonadotropin (b-HCG) and prolactine. Complete staging was negative for metastases. A typical left upper lobectomy with radical mediastinal lymph node dissection was performed. Pathology report was consistent with a poorly differentiated adenocarcinoma (T2N1M0). Immunohistochemically, multinucleate cells and occasional mononucleate tumor cells showed positivity for human chorionic gonadotropin. The patient received adjuvant chemotherapy with cisplatin - navelbine. One year later physical examination showed regression of both gynecomastia and mastodynia and there was no nipple discharge, while he is free from local or distant metastatic disease and the b-HCG level is normal (1,59 mIU/ml). This case represents a very rare, first manifestation of lung cancer. Galactorrhea, mastodynia and gynecomastia were the initial symptoms, which totally resolved following the successful surgical resection and adjuvant chemotherapy. In this case, prolactin and b-HCG are useful biomarkers during follow up for checking local or distal recurrence of the disease.
ISSN: 22130071
DOI: 10.1016/j.rmcr.2018.12.001
Rights: © Elsevier
Type: Article
Affiliation : Theagenion Anticancer Hospital 
Aristotle University of Thessaloniki 
Saint Luke Private Hospital 
Cyprus University of Technology 
Publication Type: Peer Reviewed
Appears in Collections:Άρθρα/Articles

Files in This Item:
File Description SizeFormat
1-s2.0-S2213007118302272-main.pdfFulltext1.17 MBAdobe PDFView/Open
CORE Recommender
Show full item record

SCOPUSTM   
Citations

4
checked on Nov 6, 2023

WEB OF SCIENCETM
Citations

4
Last Week
0
Last month
0
checked on Oct 29, 2023

Page view(s) 50

350
Last Week
0
Last month
2
checked on Dec 3, 2024

Download(s)

109
checked on Dec 3, 2024

Google ScholarTM

Check

Altmetric


Items in KTISIS are protected by copyright, with all rights reserved, unless otherwise indicated.